A population-based analysis of mortality in patients with Turner syndrome and hypoplastic left heart syndrome using the Texas Birth Defects Registry
Diego A. Lara1, Mary K. Ethen2, Mark A. Canfield2, Wendy N. Nembhard3, Shaine A. Morris1
1 Department of Pediatrics, Baylor College of
Medicine, Houston, TX, USA
2 Birth Defects Epidemiology and
Surveillance Branch, Texas Department of
State Health Services, Austin, TX, USA
3 University of Arkansas for Medical Sciences
and Arkansas Children’s Research Institute,
Little Rock, AR, USA
* Corresponding Author: Diego A. Lara, Ochsner Children's Medical Center, New Orleans, LA, USA. Email:
Congenital Heart Disease 2017, 12(1), 105-112.
Abstract
Background: Hypoplastic left heart syndrome (HLHS) is strongly associated with Turner syndrome
(TS); outcome data when these conditions coexist is sparse. We aimed to investigate long-term
survival and causes of death in this population.
Methods: The Texas Birth Defects Registry was queried for all live born infants with HLHS during
1999–2007. We used Kaplan–Meier and Cox regression analyses to compare survival among
patients with HLHS with TS (HLHS/TS+) to patients who had HLHS without genetic disorders or
extracardiac birth defects (HLHS/TS–).
Results: Of the 542 patients with HLHS, 11 had TS (2.0%), 71 had other extracardiac birth defects
or genetic disorders, and 463 had neither. The median follow-up time was 4.2 y (interquartile
range [IQR] 2.1–6.5). Comparing those with HLHS/TS+ to HLHS/TS–, 100% versus 35% were
female (P < .001), and median birth weight was 2140 g (IQR 1809–2650) versus 3196 g (IQR
2807–3540, P < .001). Neonatal mortality was 36% in HLHS/TS+ versus 27% in HLHS/TS– (log
rank 5 0.431). Ten of the 11 TS+ patients died during the study period for cumulative mortality
of 91% versus 50% (hazard ratio (HR) for TS+: 2.90, 95% CI 1.53–5.48). Six patients died prior to
surgery, 5 underwent Stage 1 palliation (S1P), 3 died after S1P, 2 survived past S2P, and one of
these died at age 19 mo. The underlying cause of death was listed as congenital heart disease on
all the death certificates of HLHS/TS+ patients. In multivariable analysis controlling for low birth
weight (<2500 g), TS remained associated with significantly increased cumulative mortality,
although females without TS had higher mortality than males (HR for TS+ versus males: 2.42,
95% CI 1.24–4.73; HR for TS– females versus males: 1.41, 95% CI 1.08–1.83).
Conclusion: TS with HLHS is associated with significant mortality. The increased mortality in females
without documented TS calls to question if TS is undetected in a portion of females with HLHS.
Keywords
Turner syndrome, hypoplastic left heart syndrome, sex, gender, female, population
Cite This Article
Lara, D. A., Ethen, M. K., Canfield, M. A., Nembhard, W. N., Morris, S. A. (2017). A population-based analysis of mortality in patients with Turner syndrome and hypoplastic left heart syndrome using the Texas Birth Defects Registry. Congenital Heart Disease, 12(1), 105–112.